ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,307Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 1692

$972K Total Retail Price of All Prescriptions

Rank: 44 out of 1692

398 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 398 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 398 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 13,343 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 652 596 1 7
SIMVASTATIN 512 430 2 1
AMLODIPINE BESYLATE 508 483 3 3
OMEPRAZOLE 501 397 4 5
LISINOPRIL 486 431 5 2
FENOFIBRATE 452 392 6 63
ZETIA 300 252 7 68
CRESTOR 298 255 8 26
METFORMIN HCL 284 226 9 8
PRAVASTATIN SODIUM 277 242 10 12
METOPROLOL TARTRATE 250 205 11 10
LEVOTHYROXINE SODIUM 219 201 12 4
ATORVASTATIN CALCIUM 217 195 13 11
KLOR-CON M20 193 166 14 48
HYDROCHLOROTHIAZIDE 189 158 15 9
POTASSIUM CHLORIDE 188 169 16 20
DIOVAN 184 171 17 42
ATENOLOL 184 174 17 15
WARFARIN SODIUM 175 166 19 14
DONEPEZIL HCL 169 168 20 29
GLIMEPIRIDE 159 136 21 32
SERTRALINE HCL 153 137 22 22
ZOLPIDEM TARTRATE 147 138 23 23
ALENDRONATE SODIUM 146 129 24 36
CITALOPRAM HBR 142 138 25 21
METOPROLOL SUCCINATE 141 133 26 18
CARVEDILOL 135 104 27 24
NIASPAN 133 99 28 123
TRAMADOL HCL 132 123 29 16
TAMSULOSIN HCL 132 115 29 31
VENLAFAXINE HCL ER 126 97 31 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 101 32 19
SPIRIVA 121 105 32 44
PANTOPRAZOLE SODIUM 116 116 34 39
NAMENDA 112 112 35 50
GABAPENTIN 112 109 35 13
SINGULAIR 111 80 37 79
DIGOXIN 111 100 37 85
OXYBUTYNIN CHLORIDE ER 109 98 39 152
AZITHROMYCIN 105 88 40 34
DILTIAZEM 24HR CD 104 104 41 96
NEXIUM 101 83 42 25
ALLOPURINOL 95 95 43 30
TRAZODONE HCL 94 78 44 33
DIOVAN HCT 90 59 45 73
HYDROCODONE-ACETAMINOPHEN 88 87 S3 46 6
BACLOFEN 87 61 47 115
PROAIR HFA 86 72 48 40
FLUTICASONE PROPIONATE 86 71 48 27
PREDNISONE 81 71 50 35
ADVAIR DISKUS 79 69 51 45
AMLODIPINE BESYLATE-BENAZEPRIL 79 53 51 67
AGGRENOX 77 65 53 193
DIVALPROEX SODIUM 76 76 54 97
CLOPIDOGREL 75 46 55 43
LOSARTAN POTASSIUM 75 54 55 17
MONTELUKAST SODIUM 74 50 57 144
VYTORIN 73 69 58 181
CARBIDOPA-LEVODOPA 73 73 58 110
CLONIDINE HCL 72 56 60 46
RANITIDINE HCL 64 62 61 28
ROPINIROLE HCL 63 63 62 101
WELCHOL 63 56 62 217
POLYETHYLENE GLYCOL 3350 62 59 64 64
TRICOR 62 38 64 112
IPRATROPIUM-ALBUTEROL 62 62 64 155
QUETIAPINE FUMARATE 62 62 64 62
DICLOFENAC SODIUM 59 59 68 75
PLAVIX 57 39 69 66
LIDODERM 56 56 70 138
PEN NEEDLE 55 51 71 168
NOVOLOG 54 39 72 120
LOVAZA 54 37 72 176
EXELON 53 53 74 187
KLOR-CON 10 52 45 75 159
OLANZAPINE 51 43 76 145
ACTOS 50 42 77 117
KLOR-CON M10 50 48 77 106
VENLAFAXINE HCL 50 18 77 190
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.